Optimizing DMPK Properties: Experiences from a Big Pharma DMPK Department.
Sohlenius-Sternbeck AK, Janson J, Bylund J, Baranczewski P, Breitholtz-Emanuelsson A, Hu Y, Tsoi C, Lindgren A, Gissberg O, Bueters T, Briem S, Juric S, Johansson J, Bergh M, Hoogstraate J.
Sohlenius-Sternbeck AK, et al.
Curr Drug Metab. 2016;17(3):253-70. doi: 10.2174/1389200217666151210125637.
Curr Drug Metab. 2016.
PMID: 26651977
Review.